Karel A. Schat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Karel A. Schat has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
- Keith William Jarosinski
Department of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA
4 shared publications - Arjun Challagulla
Australian Centre for Disease Preparedness, CSIRO Health and Biosecurity, Geelong, Australia
3 shared publications - Michael A. Skinner
Imperial College London
2 shared publications Michael S. Piepenbrink
2 shared publications- Timothy J. Doran
CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong 3220, Australia
2 shared publications - Ynte Hein Schukken
Infectious Disease Epidemiology, Wageningen University, Droevendaalsesteeg 1, 6708PB, Wageningen, The Netherlands.
2 shared publications
Latest Publications
- Open Access
The Importance of the Bursa of Fabricius, B Cells and T Cells for the Pathogenesis of Marek’s Disease: A Review
The importance of the bursa of Fabricius (BF) for the pathogenesis of Marek’s disease (MD) has been studied since the late 1960’s. In this review, the results of these studies are analyzed in the context of the developing knowledge of the immune system of chickens and the pathogenesis of MD from 1968 to 2022. Based on the available techniques to interfere with the development of the BF, three distinct periods are identified and discussed. During the initial period between 1968 and 1977, the use of neonatal bursectomy, chemical methods and irradiation were the main tools to interfere with the B lymphocyte development. The application of these techniques resulted in contradictory results from no effects to an increase or decrease in MD incidence. Starting in the late 1970’s, the use of bursectomy in 18-day-old embryos led to the development of the “Cornell model” for the pathogenesis of MD, in which the infection of B lymphocytes is an important first step in MD virus (MDV) replication causing the activation of thymus-derived lymphocytes (T cells). Following this model, these activated T cells, but not resting T cells, are susceptible to MDV infection and subsequent transformation. Finally, B-cell knockout chickens lacking the J gene segment of the IgY heavy chain gene were used to further define the role of the BF in the pathogenesis of MD.
Open AccessThe Importance of the Bursa of Fabricius, B Cells and T Cells for the Pathogenesis of Marek’s Disease: A Review
The importance of the bursa of Fabricius (BF) for the pathogenesis of Marek’s disease (MD) has been studied since the late 1960’s. In this review, the results of these studies are analyzed in the context of the developing knowledge of the immune system of chickens and the pathogenesis of MD from 1968 to 2022. Based on the available techniques to interfere with the development of the BF, three distinct periods are identified and discussed. During the initial period between 1968 and 1977, the use of neonatal bursectomy, chemical methods and irradiation were the main tools to interfere with the B lymphocyte development. The application of these techniques resulted in contradictory results from no effects to an increase or decrease in MD incidence. Starting in the late 1970’s, the use of bursectomy in 18-day-old embryos led to the development of the “Cornell model” for the pathogenesis of MD, in which the infection of B lymphocytes is an important first step in MD virus (MDV) replication causing the activation of thymus-derived lymphocytes (T cells). Following this model, these activated T cells, but not resting T cells, are susceptible to MDV infection and subsequent transformation. Finally, B-cell knockout chickens lacking the J gene segment of the IgY heavy chain gene were used to further define the role of the BF in the pathogenesis of MD.
- 14 January 2022
- Published by Elsevier
List of contributors
- 5 January 2022
- Published by American Association of Avian Pathologists (AAAP) in Avian Diseases
- Vol. 66 (1) , 7-19
Northeastern Conference on Avian Diseases from 1928–2021: 93 Years of Contributions to Organized Avian Medicine
Bacillary white diarrhea in chickens was a major disease concern for the poultry industry during the early 1900s. Drs. L. F. Rettger and W. R. Hinshaw organized a meeting in 1928 to discuss methods for controlling this disease. In this meeting, representatives of five northeastern states discussed approaches to test for the presence of the etiological agent of bacillary white diarrhea, namely, Salmonella enterica subsp. enterica serovar Pullorum. Meeting attendees decided to have a yearly meeting of the Northeastern Conference of Laboratory Workers in Bacillary White Diarrhea. The next year, the name was changed to Conference of Laboratory Workers in Pullorum Disease Eradication, which was changed to Northeastern Conference on Avian Diseases (NECAD) in 1957. Not only has NECAD been important for the control of pullorum disease but also, starting with the fifth Annual Conference in 1932, other poultry diseases became an official part of the program. As such, NECAD served for a long time as the premier organization to present new information on avian diseases. The success of NECAD was based on the work of the many committees, which are described in detail in this review. For example, the antigen committee started officially in 1929 and remained active until at least 1987. The main task of this committee was to evaluate Salmonella Pullorum strains to be used by all participants in the pullorum antibody testing programs. NECAD started as a closed organization with participants from universities and government organizations but did not allow representatives from commercial groups until 1968 when all American Association of Avian Pathologists (AAAP) members in the Northeastern United States could participate. The journal Avian Diseases started with discussions by Dr. P. P. Levine with M. S. Cover, H. L. Chute, R. F. Gentry, E. Jungherr, and H. Van Roekel about the idea that NECAD would sponsor a journal dealing specifically with avian diseases. During the first few years of Avian Diseases publication, many articles including abstracts came from the NECAD Annual Conferences. The importance of NECAD as a precursor for other regional meetings and the AAAP and as a forum for graduate students to present their research are described. Several recipients of the award for the best paper presented by a graduate student have continued to work in avian disease research. The decline in the participation of scientists in the late 1990s and early 2000s was discussed extensively in 2006 and led to a merger of the NECAD meeting with the Pennsylvania Poultry Sales and Service Conference. Due to the COVID-19 pandemic, the 92nd Annual Conference was a virtual meeting in 2020. Fortunately, the 93rd Annual Conference in 2021 was an in-person meeting held in State College, PA.
- 5 January 2022
- Published by American Association of Avian Pathologists (AAAP) in Avian Diseases
- Vol. 66 (1) , 7-19
Northeastern Conference on Avian Diseases from 1928–2021: 93 Years of Contributions to Organized Avian Medicine
Bacillary white diarrhea in chickens was a major disease concern for the poultry industry during the early 1900s. Drs. L. F. Rettger and W. R. Hinshaw organized a meeting in 1928 to discuss methods for controlling this disease. In this meeting, representatives of five northeastern states discussed approaches to test for the presence of the etiological agent of bacillary white diarrhea, namely, Salmonella enterica subsp. enterica serovar Pullorum. Meeting attendees decided to have a yearly meeting of the Northeastern Conference of Laboratory Workers in Bacillary White Diarrhea. The next year, the name was changed to Conference of Laboratory Workers in Pullorum Disease Eradication, which was changed to Northeastern Conference on Avian Diseases (NECAD) in 1957. Not only has NECAD been important for the control of pullorum disease but also, starting with the fifth Annual Conference in 1932, other poultry diseases became an official part of the program. As such, NECAD served for a long time as the premier organization to present new information on avian diseases. The success of NECAD was based on the work of the many committees, which are described in detail in this review. For example, the antigen committee started officially in 1929 and remained active until at least 1987. The main task of this committee was to evaluate Salmonella Pullorum strains to be used by all participants in the pullorum antibody testing programs. NECAD started as a closed organization with participants from universities and government organizations but did not allow representatives from commercial groups until 1968 when all American Association of Avian Pathologists (AAAP) members in the Northeastern United States could participate. The journal Avian Diseases started with discussions by Dr. P. P. Levine with M. S. Cover, H. L. Chute, R. F. Gentry, E. Jungherr, and H. Van Roekel about the idea that NECAD would sponsor a journal dealing specifically with avian diseases. During the first few years of Avian Diseases publication, many articles including abstracts came from the NECAD Annual Conferences. The importance of NECAD as a precursor for other regional meetings and the AAAP and as a forum for graduate students to present their research are described. Several recipients of the award for the best paper presented by a graduate student have continued to work in avian disease research. The decline in the participation of scientists in the late 1990s and early 2000s was discussed extensively in 2006 and led to a merger of the NECAD meeting with the Pennsylvania Poultry Sales and Service Conference. Due to the COVID-19 pandemic, the 92nd Annual Conference was a virtual meeting in 2020. Fortunately, the 93rd Annual Conference in 2021 was an in-person meeting held in State College, PA.
- Open Access
Primary Chicken and Duck Endothelial Cells Display a Differential Response to Infection with Highly Pathogenic Avian Influenza Virus
Highly pathogenic avian influenza viruses (HPAIVs) in gallinaceous poultry are associated with viral infection of the endothelium, the induction of a ‘cytokine storm, and severe disease. In contrast, in Pekin ducks, HPAIVs are rarely endothelial tropic, and a cytokine storm is not observed. To date, understanding these species-dependent differences in pathogenesis has been hampered by the absence of a pure culture of duck and chicken endothelial cells. Here, we use our recently established in vitro cultures of duck and chicken aortic endothelial cells to investigate species-dependent differences in the response of endothelial cells to HPAIV H5N1 infection. We demonstrate that chicken and duck endothelial cells display a different transcriptional response to HPAI H5N1 infection in vitro—with chickens displaying a more pro-inflammatory response to infection. As similar observations were recorded following in vitro stimulation with the viral mimetic polyI:C, these findings were not specific to an HPAIV H5N1 infection. However, similar species-dependent differences in the transcriptional response to polyI:C were not observed in avian fibroblasts. Taken together, these data demonstrate that chicken and duck endothelial cells display a different response to HPAIV H5N1 infection, and this may help account for the species-dependent differences observed in inflammation in vivo.
Open AccessPrimary Chicken and Duck Endothelial Cells Display a Differential Response to Infection with Highly Pathogenic Avian Influenza Virus
Highly pathogenic avian influenza viruses (HPAIVs) in gallinaceous poultry are associated with viral infection of the endothelium, the induction of a ‘cytokine storm, and severe disease. In contrast, in Pekin ducks, HPAIVs are rarely endothelial tropic, and a cytokine storm is not observed. To date, understanding these species-dependent differences in pathogenesis has been hampered by the absence of a pure culture of duck and chicken endothelial cells. Here, we use our recently established in vitro cultures of duck and chicken aortic endothelial cells to investigate species-dependent differences in the response of endothelial cells to HPAIV H5N1 infection. We demonstrate that chicken and duck endothelial cells display a different transcriptional response to HPAI H5N1 infection in vitro—with chickens displaying a more pro-inflammatory response to infection. As similar observations were recorded following in vitro stimulation with the viral mimetic polyI:C, these findings were not specific to an HPAIV H5N1 infection. However, similar species-dependent differences in the transcriptional response to polyI:C were not observed in avian fibroblasts. Taken together, these data demonstrate that chicken and duck endothelial cells display a different response to HPAIV H5N1 infection, and this may help account for the species-dependent differences observed in inflammation in vivo.
- Open Access
- 8 June 2021
- Published by MDPI AG in Methods and Protocols
- Vol. 4 (2) , 40
In Vitro Inhibition of Influenza Virus Using CRISPR/Cas13a in Chicken Cells
Advances in the field of CRISPR/Cas systems are expanding our ability to modulate cellular genomes and transcriptomes precisely and efficiently. Here, we assessed the Cas13a-mediated targeted disruption of RNA in chicken fibroblast DF1 cells. First, we developed a Tol2 transposon vector carrying the Cas13a-msGFP-NLS (pT-Cas13a) transgene, followed by a stable insertion of the Cas13a transgene into the genome of DF1 cells to generate stable DF1-Cas13a cells. To assess the Cas13a-mediated functional knockdown, DF1-Cas13a cells were transfected with the combination of a plasmid encoding DsRed coding sequence (pDsRed) and DsRed-specific crRNA (crRNA-DsRed) or non-specific crRNA (crRNA-NS). Fluorescence-activated cell sorting (FACS) and a microscopy analysis showed reduced levels of DsRed expression in cells transfected with crRNA-DsRed but not in crRNA-NS, confirming a sequence-specific Cas13a mediated mRNA knockdown. Next, we designed four crRNAs (crRNA-IAV) against the PB1, NP and M genes of influenza A virus (IAV) and cloned in tandem to express from a single vector. DF1-Cas13a cells were transfected with plasmids encoding the crRNA-IAV or crRNA-NS, followed by infection with WSN or PR8 IAV. DF1 cells transfected with crRNA-IAV showed reduced levels of viral titers compared to cells transfected with crRNA-NS. These results demonstrate the potential of Cas13a as an antiviral strategy against highly pathogenic strains of IAV in chickens.
- 8 June 2021
- Published by MDPI AG in Methods and Protocols
- Vol. 4 (2) , 40
Open AccessIn Vitro Inhibition of Influenza Virus Using CRISPR/Cas13a in Chicken Cells
Advances in the field of CRISPR/Cas systems are expanding our ability to modulate cellular genomes and transcriptomes precisely and efficiently. Here, we assessed the Cas13a-mediated targeted disruption of RNA in chicken fibroblast DF1 cells. First, we developed a Tol2 transposon vector carrying the Cas13a-msGFP-NLS (pT-Cas13a) transgene, followed by a stable insertion of the Cas13a transgene into the genome of DF1 cells to generate stable DF1-Cas13a cells. To assess the Cas13a-mediated functional knockdown, DF1-Cas13a cells were transfected with the combination of a plasmid encoding DsRed coding sequence (pDsRed) and DsRed-specific crRNA (crRNA-DsRed) or non-specific crRNA (crRNA-NS). Fluorescence-activated cell sorting (FACS) and a microscopy analysis showed reduced levels of DsRed expression in cells transfected with crRNA-DsRed but not in crRNA-NS, confirming a sequence-specific Cas13a mediated mRNA knockdown. Next, we designed four crRNAs (crRNA-IAV) against the PB1, NP and M genes of influenza A virus (IAV) and cloned in tandem to express from a single vector. DF1-Cas13a cells were transfected with plasmids encoding the crRNA-IAV or crRNA-NS, followed by infection with WSN or PR8 IAV. DF1 cells transfected with crRNA-IAV showed reduced levels of viral titers compared to cells transfected with crRNA-NS. These results demonstrate the potential of Cas13a as an antiviral strategy against highly pathogenic strains of IAV in chickens.
- 19 March 2021
- Published by American Association of Avian Pathologists (AAAP) in Avian Diseases
- Vol. 65 (2) , 227-236
Pullorum Disease: Evolution of the Eradication Strategy
The history of pullorum disease is closely intertwined with the history of avian health research and that of the poultry industry. The seriousness of the disease galvanized the attention and brought together, for the first time, the pioneers of poultry health research to work cooperatively on different aspects of the disease. Control of the disease made it possible for intensive poultry production to develop as the basis for the modern poultry industry. During the early 1900s, bacillary white diarrhea (BWD) was a devastating disease of young chickens threatening the developing poultry industry. Dr. Leo F. Rettger isolated and described the bacterial pathogen, Salmonella enterica serotype Pullorum, for the first time in 1900. BWD was renamed pullorum disease in 1929. In subsequent years, Rettger and coworkers were able to reproduce the disease and fulfill Koch's postulates. Rettger et al. also showed that Salmonella Pullorum was vertically transmitted, which was the first time that a pathogen was shown to be vertically transmitted. The development of serologic tests was of crucial importance because it led to the development of effective eradication methods to identify carrier birds and to exclude these birds from the breeder flocks. The negative impact of pullorum disease on the poultry industry ultimately was one of the major reasons that the National Poultry Improvement Plan (NPIP) was developed by scientists, the poultry industry, and the United States Department of Agriculture (USDA). Needless to say, the work of the pioneering researchers formed the basis for the control of the disease. The NPIP started in 1935, with 34 states participating in testing 4 million birds representing 58.2% of the birds hatched. The program rapidly expanded to 47 states by 1948 and tested more than 30 million birds. In 1967, all commercial chicken hatcheries participating in the NPIP were 100% free of pullorum and typhoid disease caused by Salmonella enterica serotype Gallinarum. This historical overview of pullorum disease describes in some detail the progress made, especially during the early years, toward controlling this disease using methodologies that were often very basic but nonetheless effective. One has to admire the ingenuity and persistence of the early researchers leading to their achievements considering the research tools that were available at the time.
- 19 March 2021
- Published by American Association of Avian Pathologists (AAAP) in Avian Diseases
- Vol. 65 (2) , 227-236
Pullorum Disease: Evolution of the Eradication Strategy
The history of pullorum disease is closely intertwined with the history of avian health research and that of the poultry industry. The seriousness of the disease galvanized the attention and brought together, for the first time, the pioneers of poultry health research to work cooperatively on different aspects of the disease. Control of the disease made it possible for intensive poultry production to develop as the basis for the modern poultry industry. During the early 1900s, bacillary white diarrhea (BWD) was a devastating disease of young chickens threatening the developing poultry industry. Dr. Leo F. Rettger isolated and described the bacterial pathogen, Salmonella enterica serotype Pullorum, for the first time in 1900. BWD was renamed pullorum disease in 1929. In subsequent years, Rettger and coworkers were able to reproduce the disease and fulfill Koch's postulates. Rettger et al. also showed that Salmonella Pullorum was vertically transmitted, which was the first time that a pathogen was shown to be vertically transmitted. The development of serologic tests was of crucial importance because it led to the development of effective eradication methods to identify carrier birds and to exclude these birds from the breeder flocks. The negative impact of pullorum disease on the poultry industry ultimately was one of the major reasons that the National Poultry Improvement Plan (NPIP) was developed by scientists, the poultry industry, and the United States Department of Agriculture (USDA). Needless to say, the work of the pioneering researchers formed the basis for the control of the disease. The NPIP started in 1935, with 34 states participating in testing 4 million birds representing 58.2% of the birds hatched. The program rapidly expanded to 47 states by 1948 and tested more than 30 million birds. In 1967, all commercial chicken hatcheries participating in the NPIP were 100% free of pullorum and typhoid disease caused by Salmonella enterica serotype Gallinarum. This historical overview of pullorum disease describes in some detail the progress made, especially during the early years, toward controlling this disease using methodologies that were often very basic but nonetheless effective. One has to admire the ingenuity and persistence of the early researchers leading to their achievements considering the research tools that were available at the time.
- Open Access
- 13 January 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (1) , 164
In Vivo Inhibition of Marek’s Disease Virus in Transgenic Chickens Expressing Cas9 and gRNA against ICP4
Marek’s disease (MD), caused by MD herpesvirus (MDV), is an economically important disease in chickens. The efficacy of the existing vaccines against evolving virulent stains may become limited and necessitates the development of novel antiviral strategies to protect poultry from MDV strains with increased virulence. The CRISPR/Cas9 system has emerged as a powerful genome editing tool providing an opportunity to develop antiviral strategies for the control of MDV infection. Here, we characterized Tol2 transposon constructs encoding Cas9 and guide RNAs (gRNAs) specific to the immediate early infected-cell polypeptide-4 (ICP4) of MDV. We generated transgenic chickens that constitutively express Cas9 and ICP4-gRNAs (gICP4) and challenged them via intraabdominal injection of MDV-1 Woodlands strain passage-19 (p19). Transgenic chickens expressing both gRNA/Cas9 had a significantly reduced replication of MDV in comparison to either transgenic Cas9-only or the wild-type (WT) chickens. We further confirmed that the designed gRNAs exhibited sequence-specific virus interference in transgenic chicken embryo fibroblast (CEF) expressing Cas9/gICP4 when infected with MDV but not with herpesvirus of turkeys (HVT). These results suggest that CRISPR/Cas9 can be used as an antiviral approach to control MDV infection in chickens, allowing HVT to be used as a vector for recombinant vaccines.
- 13 January 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (1) , 164
Open AccessIn Vivo Inhibition of Marek’s Disease Virus in Transgenic Chickens Expressing Cas9 and gRNA against ICP4
Marek’s disease (MD), caused by MD herpesvirus (MDV), is an economically important disease in chickens. The efficacy of the existing vaccines against evolving virulent stains may become limited and necessitates the development of novel antiviral strategies to protect poultry from MDV strains with increased virulence. The CRISPR/Cas9 system has emerged as a powerful genome editing tool providing an opportunity to develop antiviral strategies for the control of MDV infection. Here, we characterized Tol2 transposon constructs encoding Cas9 and guide RNAs (gRNAs) specific to the immediate early infected-cell polypeptide-4 (ICP4) of MDV. We generated transgenic chickens that constitutively express Cas9 and ICP4-gRNAs (gICP4) and challenged them via intraabdominal injection of MDV-1 Woodlands strain passage-19 (p19). Transgenic chickens expressing both gRNA/Cas9 had a significantly reduced replication of MDV in comparison to either transgenic Cas9-only or the wild-type (WT) chickens. We further confirmed that the designed gRNAs exhibited sequence-specific virus interference in transgenic chicken embryo fibroblast (CEF) expressing Cas9/gICP4 when infected with MDV but not with herpesvirus of turkeys (HVT). These results suggest that CRISPR/Cas9 can be used as an antiviral approach to control MDV infection in chickens, allowing HVT to be used as a vector for recombinant vaccines.
- 2 August 2016
- Published by American Association of Avian Pathologists (AAAP) in Avian Diseases
- Vol. 60 (4) , 715-724
History of the First-Generation Marek's Disease Vaccines: The Science and Little-Known Facts
SUMMARY Shortly after the isolation of Marek's disease (MD) herpesvirus (MDV) in the late 1960s vaccines were developed in England, the United States, and The Netherlands. Biggs and associates at the Houghton Poultry Research Station (HPRS) in England attenuated HPRS-16, the first cell-culture–isolated MDV strain, by passaging HPRS-16 in chick kidney cells. Although HPRS-16/Att was the first commercially available vaccine, it never became widely used and was soon replaced by the FC126 strain of herpesvirus of turkeys (HVT) vaccine developed by Witter and associates at the Regional Poultry Research Laboratory (now Avian Disease and Oncology Laboratory [ADOL]) in East Lansing, MI. Ironically, Kawamura et al. isolated a herpesvirus from kidney cell cultures from turkeys in 1969 but never realized its potential as a vaccine against MD. Rispens of the Central Veterinary Institute (CVI) developed the third vaccine. His associate, Maas, had found commercial flocks of chickens with MDV antibodies but without MD. ... RESUMEN Artículo Histórico - Historia de las vacunas de primera generación contra la enfermedad de Marek: La ciencia y algunos datos poco conocidos. Poco después del aislamiento del herpesvirus de la enfermedad de Marek (MDV) a finales de la década de los 1960s se desarrollaron vacunas en Inglaterra, en los Estados Unidos y en los Países Bajos. Biggs y sus colaboradores en la Estación de Investigación Avícola en Houghton (con las siglas en inglés HPRS) en Inglaterra, atenuaron el virus HPRS-16, que fue la primera cepa del virus de Marek aislada en cultivo celular y fue atenuada mediante pasajes en cultivos celulares de células de riñón de pollo. Aunque la cepa HPRS-16/Att fue la primera vacuna disponible comercialmente, nunca llegó a ser ampliamente utilizada y pronto fue sustituida por la cepa FC126 que es una vacuna con un herpesvirus de pavos (HVT) desarrollada por Witter y colaboradores en el Laboratorio de Investigación Avícola Regional (ahora llamado Laboratorio de Enfermedades y Oncología Aviares [...
- 2 August 2016
- Published by American Association of Avian Pathologists (AAAP) in Avian Diseases
- Vol. 60 (4) , 715-724
History of the First-Generation Marek's Disease Vaccines: The Science and Little-Known Facts
SUMMARY Shortly after the isolation of Marek's disease (MD) herpesvirus (MDV) in the late 1960s vaccines were developed in England, the United States, and The Netherlands. Biggs and associates at the Houghton Poultry Research Station (HPRS) in England attenuated HPRS-16, the first cell-culture–isolated MDV strain, by passaging HPRS-16 in chick kidney cells. Although HPRS-16/Att was the first commercially available vaccine, it never became widely used and was soon replaced by the FC126 strain of herpesvirus of turkeys (HVT) vaccine developed by Witter and associates at the Regional Poultry Research Laboratory (now Avian Disease and Oncology Laboratory [ADOL]) in East Lansing, MI. Ironically, Kawamura et al. isolated a herpesvirus from kidney cell cultures from turkeys in 1969 but never realized its potential as a vaccine against MD. Rispens of the Central Veterinary Institute (CVI) developed the third vaccine. His associate, Maas, had found commercial flocks of chickens with MDV antibodies but without MD. ... RESUMEN Artículo Histórico - Historia de las vacunas de primera generación contra la enfermedad de Marek: La ciencia y algunos datos poco conocidos. Poco después del aislamiento del herpesvirus de la enfermedad de Marek (MDV) a finales de la década de los 1960s se desarrollaron vacunas en Inglaterra, en los Estados Unidos y en los Países Bajos. Biggs y sus colaboradores en la Estación de Investigación Avícola en Houghton (con las siglas en inglés HPRS) en Inglaterra, atenuaron el virus HPRS-16, que fue la primera cepa del virus de Marek aislada en cultivo celular y fue atenuada mediante pasajes en cultivos celulares de células de riñón de pollo. Aunque la cepa HPRS-16/Att fue la primera vacuna disponible comercialmente, nunca llegó a ser ampliamente utilizada y pronto fue sustituida por la cepa FC126 que es una vacuna con un herpesvirus de pavos (HVT) desarrollada por Witter y colaboradores en el Laboratorio de Investigación Avícola Regional (ahora llamado Laboratorio de Enfermedades y Oncología Aviares [...
- 1 June 2013
- Published by American Association of Avian Pathologists (AAAP) in Avian Diseases
- Vol. 57 (2s1) , 503-508
Importance of Differential Expression of Marek's Disease Virus Gene pp38 for the Pathogenesis of Marek's Disease
The role of pp38 in the pathogenesis of Marek's disease (MD) has not been fully elucidated. Previously, we reported the presence of two splice variants (Spl A and Spl B) for pp38. We also reported that the wild-type pp38 (WT), as well as the mutated pp38 (MUT), altered the oxidative phosphorylation pathway in infected cells. To determine whether the different forms of pp38 are important for the pathogenesis of MD, we generated RB-1B-based bacterial artificial chromosome (BAC) clones expressing pp38MUT, pp38Sp1 A, and pp38Spl B. Infectious viruses were recovered from these BAC clones in chick kidney cells (CKC). The Spl A and Spl B viruses had significantly smaller plaque sizes and replicated to a lesser degree in CKC than the WT and MUT viruses. Two in vivo experiments were conducted by inoculating 7-day-old P2a chicks with 1000 plaque-forming units of each virus. In the first experiment, chicks were sacrificed at 4, 8, 11, and 15 days postinfection (PI). WT and MUT viruses had similar viremia levels using virus isolation and quantitative real-time PCR (qPCR) assays, whereas Spl A and Spl B viruses had significantly lower viremia levels than WT and MUT viruses. In the second experiment, we showed that tumor development and MD mortality were similar in the WT- and MUT-infected chickens, with all birds MD positive at 5 wk PI. In contrast, chickens infected with Spl B and Spl A had a significantly lower MD incidence at 11 wk PI, when the experiment was terminated.
- 1 June 2013
- Published by American Association of Avian Pathologists (AAAP) in Avian Diseases
- Vol. 57 (2s1) , 503-508
Importance of Differential Expression of Marek's Disease Virus Gene pp38 for the Pathogenesis of Marek's Disease
The role of pp38 in the pathogenesis of Marek's disease (MD) has not been fully elucidated. Previously, we reported the presence of two splice variants (Spl A and Spl B) for pp38. We also reported that the wild-type pp38 (WT), as well as the mutated pp38 (MUT), altered the oxidative phosphorylation pathway in infected cells. To determine whether the different forms of pp38 are important for the pathogenesis of MD, we generated RB-1B-based bacterial artificial chromosome (BAC) clones expressing pp38MUT, pp38Sp1 A, and pp38Spl B. Infectious viruses were recovered from these BAC clones in chick kidney cells (CKC). The Spl A and Spl B viruses had significantly smaller plaque sizes and replicated to a lesser degree in CKC than the WT and MUT viruses. Two in vivo experiments were conducted by inoculating 7-day-old P2a chicks with 1000 plaque-forming units of each virus. In the first experiment, chicks were sacrificed at 4, 8, 11, and 15 days postinfection (PI). WT and MUT viruses had similar viremia levels using virus isolation and quantitative real-time PCR (qPCR) assays, whereas Spl A and Spl B viruses had significantly lower viremia levels than WT and MUT viruses. In the second experiment, we showed that tumor development and MD mortality were similar in the WT- and MUT-infected chickens, with all birds MD positive at 5 wk PI. In contrast, chickens infected with Spl B and Spl A had a significantly lower MD incidence at 11 wk PI, when the experiment was terminated.